Loading...

Ovoca Bio plc

OVB.LLSE
Healthcare
Biotechnology
£1.15
£-0.13(-9.80%)

Ovoca Bio plc (OVB.L) Company Profile & Overview

Explore Ovoca Bio plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Ovoca Bio plc (OVB.L) Company Profile & Overview

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.

SectorHealthcare
IndustryBiotechnology
CEOMr. Timothy Rand McCutcheon

Contact Information

353 1 661 9819
17 Pembroke Street Upper, Dublin, 2

Company Facts

5 Employees
IPO DateJan 4, 2000
CountryIE

Frequently Asked Questions